Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Interim Serum Soluble Interleukin-2 Receptor Levels Are Strongly Associated with Prognosis in Newly Diagnosis DLBCL Patients

Haruya Okamoto, MD, Akihiro Miyashita, MD, Hiroaki Nagata, MD, Yasuhiko Tsutsumi, MD PhD, Yuri Kamitsuji, MD PhD, Yutaka Kobayashi, MD PhD, Nobuhiko Uoshima, MD PhD

Blood (2019) 134 (Supplement_1): 4118.

https://doi.org/10.1182/blood-2019-122375

Published: 2019

Journal Articles

Identification of Clonal Immunoglobulin λ Light-Chain Gene Rearrangements in AL Amyloidosis Using Next Generation Sequencing

Blood (2019) 134 (Supplement_1): 1748.

https://doi.org/10.1182/blood-2019-125028

Published: 2019

Journal Articles

In Elderly Patients with Newly Diagnosed Aggressive B-Cell Lymphoma, the Rate of Change in Body Weight after the First Course R-CHOP (-like) Chemo Therapy Has Effect on Their Survival

Muramatsu Ayako, MD, Nagata Hiroaki, MD, Kuriyama Kodai, MD PhD, Hirakawa Yoshiko, MD PhD, Oshiro Muneo, MD PhD, Iwai Toshiki, MD PhD, Uchiyama Hitoji, MD PhD

Blood (2018) 132 (Supplement 1): 4238.

https://doi.org/10.1182/blood-2018-99-117207

Published: 2018

Journal Articles

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Kyoko Fuse, MD, Tomoyuki Tanaka, MD PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5260.

https://doi.org/10.1182/blood-2018-99-113251

Published: 2018

Journal Articles

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Hirofumi Nakano, MD, Kazuya Sato, MD PhD, Hiroko Hayakawa, PhD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Kaoru Morita, MD PhD, Ryoko Yamasaki, MD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 3320.

https://doi.org/10.1182/blood-2018-99-110011

Published: 2018

Journal Articles

A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness

Laurence Corash, MD, Joycelyn Sim, MDMBBS, Wai-Chiu Tsoi, MD, Cheuk Kwong Lee, MD, Rock Y.Y. Leung, MD, Yingjie Liu, MD, Norman Huang, PhD, Clarence C.K. Lam, Hans Vermeij, Adonis Stassinopoulos, PhD BSc, MPhil, MA, Richard J. Benjamin, MD, Albert Kwok Wai Lie, MBBS,FRCP,FRCPath,FRCPA

Blood (2018) 132 (Supplement 1): 1257.

https://doi.org/10.1182/blood-2018-99-112305

Published: 2018

Journal Articles

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Yasufumi Kawasaki, MD PhD, Kazuya Sato, MDPhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2018-99-111773

Published: 2018

Journal Articles

Efficacy of HLA-Matched PLT Transfusions for Platelet Transfusion Refractoriness in HSCT Patients

Keisuke Seike, Nobuharu Fujii, MD PhD, Keiko Fujii, MD PhD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Kyosuke Saeki, MD, Yusuke Meguri, MD, Noboru Asada, MD PhD, Daisuke Ennishi, MDPhD, Hisakazu Nishimori, MD PhD, Ken-Ichi Matsuoka, MD PhD, Yoshinobu Maeda, MDPhD

Blood (2018) 132 (Supplement 1): 1265.

https://doi.org/10.1182/blood-2018-99-112365

Published: 2018

Journal Articles

Clinical Significance of Natural Killer Cell-Mediated Alloreactivity in Unrelated Cord Blood Transplantation for Children with Acute Leukemia: A Japanese National Registry Study

Hirotoshi Sakaguchi, MD PhD, Nobuyoshi Arima, MD PhD, Atsushi Narita, MD PhD, Sae Ishimaru, MD, Daisuke Tomizawa, MD PhD, Daiichiro Hasegawa, MD PhD, Motohiro Kato, MD, Hiroyuki Ishida, MD PhD, Junya Kanda, MD, Masami Inoue, MD PhD, Nao Yoshida, MD PhD, Katsuyoshi Koh, MD, Jiro Inagaki, MD PhD, Atsushi Ogawa, MD PhD, Tsukasa Hori, MD PhD, Yoshiko Hashii, MD, PhD, Koji Kato, MD, PhD, Yoshiko Atsuta, MD PhD

Blood (2017) 130 (Supplement 1): 3315.

https://doi.org/10.1182/blood.V130.Suppl_1.3315.3315

Published: 2017

Journal Articles

Translocation (11;14) and Survival of Patients with AL Amyloidosis and Multiple Myeloma

Takao Yogo, Kanji Miyazaki, Kenshi Suzuki

Blood (2017) 130 (Supplement 1): 5333.

https://doi.org/10.1182/blood.V130.Suppl_1.5333.5333

Published: 2017

Journal Articles

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Kyoko Fuse, MD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2017) 130 (Supplement 1): 2044.

https://doi.org/10.1182/blood.V130.Suppl_1.2044.2044

Published: 2017

Journal Articles

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

M. Tayyeb Ayyoubi, MD, Suresh Manapuram, MD, Hamza Hashmi, MD, Katherine McDaniel, MLS (ASCP), Soumit K. Basu, MD PhD, William Tse, MD, Maxwell M. Krem, MD PhD

Blood (2017) 130 (Supplement 1): 4928.

https://doi.org/10.1182/blood.V130.Suppl_1.4928.4928

Published: 2017

Journal Articles

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Kenshi Suzuki, MD PhD, Tomofumi Yamamoto, Masahiro Ikeda, MD, Tomomi Takei, MD, Nobuhiro Tsukada, MD PhD, Tadao Ishida, MD PhD, Arimi Ueda, Daiju Ichikawa, PhD, Maiko Matsushita, MD PhD, Yutaka Hattori, MD PhD

Blood (2016) 128 (22): 5620.

https://doi.org/10.1182/blood.V128.22.5620.5620

Published: 2016

Journal Articles

Manufacture of Platelets from Human Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells: Functional Comparison to Concentrate Platelets

Keiichi Tozawa, MD, Yukako Ono-Uruga, MD PhD, Masaki Yazawa, MD PhD, Taisuke Mori, PhD, Noriko Takizawa, Mitsuru Murata, MD PhD, Shinichiro Okamoto, MD PhD, Yasuo Ikeda, MD PhD, Yumiko Matsubara, PhD

Blood (2016) 128 (22): 1028.

https://doi.org/10.1182/blood.V128.22.1028.1028

Published: 2016

Journal Articles

REG3A Polymorphism Is Associated with the Incidence of Extensive Chronic Gvhd after Allogeneic BMT

Daisuke Koyama, MD, Makoto Murata, MD PhD, Ryo Hanajiri, MD PhD, Shingo Okuno, MD, Sonoko Kamoshita, MD, Jakrawadee Julamanee, MD, Erina Takagi, MD, Kotaro Miyao, MD, Reona Sakemura, MD, Tatsunori Goto, MD, Aika Seto, MD, Yukiyasu Ozawa, MD PhD, Koichi Miyamura, MD PhD, Seitaro Terakura, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2016) 128 (22): 3426.

https://doi.org/10.1182/blood.V128.22.3426.3426

Published: 2016

Journal Articles

Treatment Use Study of Platelet Components Treated with Amotosalen and Ultraviolet a Light in Response to Emerging Arboviruses in Puerto Rico - True Study Final Results

Salvador Rico, Susan L. Stramer, PhD, Richard J. Benjamin, MD PhD, Edgardo Cartagena, Axel Arroyo, Nelson Robles, Simon Carlo, L Vera, P Solivan-Ortiz, Norman Huang, Claudia Koontz, Travis Berry, Laurence Corash

Blood (2016) 128 (22): 3844.

https://doi.org/10.1182/blood.V128.22.3844.3844

Published: 2016

Journal Articles

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Kyoko Fuse, MD, Takayuki Katagiri, MD, Yasuhiko Shibasaki, MD PhD, Tomoyuki Tanaka, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD, Tatsuo Furukawa, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Takashi Ushiki, MD PhD

Blood (2016) 128 (22): 2297.

https://doi.org/10.1182/blood.V128.22.2297.2297

Published: 2016

Journal Articles

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Tsutomu Kobayashi, MD PhD, Junya Kuroda, MD PhD, Isao Yokota, PhD, Kazuna Tanba, MD, Tomohiko Taki, MD PhD, Takahiro Fujino, MD, Saeko Kuwahara, MD, Reiko Isa, MD, Junko Yamaguchi, MD, Eri Kawata, MD PhD, Teruaki Akaogi, MD, Hitoji Uchiyama, MD PhD, Hiroto Kaneko, MD, Nobuhiko Uoshima, MD PhD, Yutaka Kobayashi, MD PhD, Satoshi Teramukai, PhD, Masafumi Taniwaki

Blood (2015) 126 (23): 3877.

https://doi.org/10.1182/blood.V126.23.3877.3877

Published: 2015

Journal Articles

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

Kenshi Suzuki, Miho Kasuga, trainee, Kanji Miyazaki, MD, Sohsuke Meshitsuka, MD, Yu ABE, MD, Yumiko Yoshiki, MD PhD, Nobuhiro Tsukada, MD PhD

Blood (2015) 126 (23): 4224.

https://doi.org/10.1182/blood.V126.23.4224.4224

Published: 2015

Journal Articles

A Serum Biomarker Panel Composed of C-Reactive Protein and Albumin Could Predict the Transplant-Related Complications and the Outcomes of Allogeneic Hematopoietic Cell Transplantation

Kazutaka Ozeki, MD PhD, Yukiyasu Ozawa, MD, Naomi Kawashima, MD, Yusuke Yamaga, MD, Yoshitaka Adachi, MD, Koji Umemura, MD, Shoichiro Okazaki, MD, Akio Kohno, MD PhD, Koichi Miyamura, MD PhD, Yoshihisa Morishita, MD PhD

Blood (2015) 126 (23): 3147.

https://doi.org/10.1182/blood.V126.23.3147.3147

Published: 2015

NARROW

Interim Serum Soluble Interleukin-2 Receptor Levels Are Strongly Associated with Prognosis in Newly Diagnosis DLBCL Patients

Identification of Clonal Immunoglobulin λ Light-Chain Gene Rearrangements in AL Amyloidosis Using Next Generation Sequencing

In Elderly Patients with Newly Diagnosed Aggressive B-Cell Lymphoma, the Rate of Change in Body Weight after the First Course R-CHOP (-like) Chemo Therapy Has Effect on Their Survival

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Efficacy of HLA-Matched PLT Transfusions for Platelet Transfusion Refractoriness in HSCT Patients

Clinical Significance of Natural Killer Cell-Mediated Alloreactivity in Unrelated Cord Blood Transplantation for Children with Acute Leukemia: A Japanese National Registry Study

Translocation (11;14) and Survival of Patients with AL Amyloidosis and Multiple Myeloma

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Manufacture of Platelets from Human Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells: Functional Comparison to Concentrate Platelets

REG3A Polymorphism Is Associated with the Incidence of Extensive Chronic Gvhd after Allogeneic BMT

Treatment Use Study of Platelet Components Treated with Amotosalen and Ultraviolet a Light in Response to Emerging Arboviruses in Puerto Rico - True Study Final Results

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

A Serum Biomarker Panel Composed of C-Reactive Protein and Albumin Could Predict the Transplant-Related Complications and the Outcomes of Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only